Tavanta concludes subject enrolment in Phase III prostate cancer trial
The company anticipates topline data from the trial in the fourth quarter of this year.
Male Health
Latest in
Male Health
Increase in prostate cancer screening after rollout of revised national guidelines
GlobalData epidemiologists expect that the rise in prostate cancer screening may lead to an increase in diagnosed cases in the…
By
Slow progress for male contraceptive trials
Options for male contraception are still extremely limited, with only 31 clinical trials ongoing at the most recent count.
By
Astellas-Pfizer’s Xtandi reduces mortality risk in prostate cancer trial
The safety profile of Xtandi in treatment arms was in line with the results from the initial analysis.
Pfizer initiates dosing in Phase III prostate cancer drug trial
TALAPRO-3 will enrol 550 men with DDR-deficient mCSPC at about 285 sites in 28 countries.
Telix begins Phase III prostate cancer treatment trial
Telix Pharmaceuticals has begun a Phase III ProstACT clinical trial of its therapy candidate, TLX591 (177Lu-DOTA-rosopatamab), in advanced metastatic castrate-resistant…
Can Merck overcome challenges in an immunologically “cold” tumour with Keytruda for prostate cancer?
Prostate cancers are slow-moving tumours and are generally regarded as immunologically “cold”.
By
AstraZeneca and MSD report positive data from trial of Lynparza
AstraZeneca and MSD have reported positive results from the Phase III PROfound trial evaluating the safety and efficacy of Lynparza…